Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-027918

Chief Financial Officer sold 1,792 shares at $18.73 ($33,560)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FRATES JAMES M Chief Financial Officer 2024-03-05 Sale −1,792 $18.73 $33,560 134,784 D
Open-market sales · 1,792 sh · avg $18.73 · $33,560
Loading xslF345X05/ownership.xml…